Literature DB >> 17549728

Patterns of expression of the Follistatin and Follistatin-like1 genes during chicken heart development: a potential role in valvulogenesis and late heart muscle cell formation.

Gert van den Berg1, Semir Somi, Anita A M Buffing, Antoon F M Moorman, Maurice J B van den Hoff.   

Abstract

The regulation of concentration and function of growth factors is of crucial importance to proper embryonic development of the heart. The patterns of expression of three extracellular modulators of the transforming growth factor-beta superfamily of growth factors, Follistatin, Follistatin-like1, and Follistatin-like3, are described with respect to heart development. Follistatin is highly localized in the endocardium covering the developing cardiac valves. Follistatin-like1 is localized in the mesenchymal filling of the pharyngeal arches and broadly expressed in cells directly bordering myocardium. Follistatin-like3 is not expressed in the heart. Taken together, these observations are suggestive for a role for Follistatin in cardiac valvulogenesis and a role for Follistatin-like1 in controlling late heart muscle cell formation. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17549728     DOI： 10.1002/ar.20559

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN： 1932-8486            Impact factor:   2.064


  9 in total

1.  Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.

Authors:  Masayuki Shimano; Noriyuki Ouchi; Kazuto Nakamura; Bram van Wijk; Koji Ohashi; Yasuhide Asaumi; Akiko Higuchi; David R Pimentel; Flora Sam; Toyoaki Murohara; Maurice J B van den Hoff; Kenneth Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

2.  beta(1)-Adrenergic receptor vs adenylyl cyclase 6 expression in cardiac myocytes: differences in transgene localization and intracellular signaling.

Authors:  Mei Hua Gao; Tong Tang; Atsushi Miyanohara; James R Feramisco; H Kirk Hammond
Journal:  Cell Signal       Date:  2009-11-20       Impact factor: 4.315

3.  Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling.

Authors:  Buel D Rodgers; Jillian P Interlichia; Dilip K Garikipati; Ranganath Mamidi; Murali Chandra; O Lynne Nelson; Charles E Murry; Luis F Santana
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

4.  Mesendodermal signals required for otic induction: Bmp-antagonists cooperate with Fgf and can facilitate formation of ectopic otic tissue.

Authors:  Hye-Joo Kwon; Bruce B Riley
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

5.  The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis.

Authors:  Marc Sylva; Vivian S W Li; Anita A A Buffing; Johan H van Es; Maaike van den Born; Saskia van der Velden; Quinn Gunst; Jan Harm Koolstra; Antoon F M Moorman; Hans Clevers; Maurice J B van den Hoff
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

6.  Proteomic characterization of epicardial-myocardial signaling reveals novel regulatory networks including a role for NF-κB in epicardial EMT.

Authors:  Yanyang Li; Alexander Urban; Devin Midura; Hans-Georg Simon; Q Tian Wang
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

Review 7.  Follistatin-like 1 in development and human diseases.

Authors:  Andrea Mattiotti; Stuti Prakash; Phil Barnett; Maurice J B van den Hoff
Journal:  Cell Mol Life Sci       Date:  2018-03-29       Impact factor: 9.261

8.  Follistatin-like 1 promotes proliferation of matured human hypoxic iPSC-cardiomyocytes and is secreted by cardiac fibroblasts.

Authors:  Marijn C Peters; Sofia Di Martino; Thomas Boelens; Jiabin Qin; Alain van Mil; Pieter A Doevendans; Steven A J Chamuleau; Joost P G Sluijter; Klaus Neef
Journal:  Mol Ther Methods Clin Dev       Date:  2022-02-23       Impact factor: 6.698

9.  BMPER Promotes Epithelial-Mesenchymal Transition in the Developing Cardiac Cushions.

Authors:  Laura Dyer; Pamela Lockyer; Yaxu Wu; Arnab Saha; Chelsea Cyr; Martin Moser; Xinchun Pi; Cam Patterson
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.